ArthroCare Corp. Price Target Increased to $46.00 by Analysts at Piper Jaffray Cos. (ARTC)
Research analysts at Piper Jaffray Cos. boosted their price target on shares of ArthroCare Corp. (NASDAQ:ARTC) from $43.00 to $46.00 in a report released on Friday, AnalystRatings.NET reports. The firm currently has an “overweight” rating on the stock. Piper Jaffray Cos.’s price target indicates a potential upside of 25.44% from the stock’s previous close.
In other ArthroCare Corp. news, SVP Jean Woloszko unloaded 1,342 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $37.95, for a total transaction of $50,928.90. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of ArthroCare Corp. (NASDAQ:ARTC) opened at 36.67 on Friday. ArthroCare Corp. has a 52 week low of $30.47 and a 52 week high of $38.50. The stock has a 50-day moving average of $36.06 and a 200-day moving average of $34.99. The company has a market cap of $1.040 billion and a P/E ratio of 71.31.
ArthroCare Corp. (NASDAQ:ARTC) last released its earnings data on Wednesday, October 30th. The company reported $0.27 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.27. The company had revenue of $91.86 million for the quarter, compared to the consensus estimate of $88.99 million. During the same quarter last year, the company posted $0.27 earnings per share. ArthroCare Corp.’s revenue was up 5.7% compared to the same quarter last year. Analysts expect that ArthroCare Corp. will post $1.46 EPS for the current fiscal year.
ARTC has been the subject of a number of other recent research reports. Analysts at Canaccord Genuity raised their price target on shares of ArthroCare Corp. from $45.00 to $48.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Analysts at TheStreet downgraded shares of ArthroCare Corp. from a “buy” rating to a “hold” rating in a research note to investors on Friday, August 23rd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $44.00.
ArthroCare Corporation (NASDAQ:ARTC), is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.